Rchr
J-GLOBAL ID:201801014065560363   Update date: Jan. 11, 2024

Hisayuki Hashimoto

ハシモト ヒサユキ | Hisayuki Hashimoto
Affiliation and department:
Research field  (4): Anatomy ,  Genomics ,  Pathobiochemistry ,  Cardiology
Research keywords  (7): 転写因子 ,  エピジェネティクス ,  分子生物学 ,  心不全 ,  幹細胞 ,  リプログラミング ,  再生医療
Research theme for competitive and other funds  (21):
  • 2023 - 2026 細胞移植療法の最適化に向けた生体内移植細胞の非侵襲的検出技術の開発
  • 2022 - 2025 Dissecting the transcriptional network of organogenesis based on reprogramming factors
  • 2022 - 2023 中胚葉において循環器形成細胞が誘導される分子基盤解明
  • 2021 - 2023 エピゲノム編集による心筋分化転換法の確立
  • 2019 - 2022 Dissecting the cardiogenic network of ZNF281
Show all
Papers (38):
  • Jin Komuro, Dai Kusumoto, Hisayuki Hashimoto, Shinsuke Yuasa. Machine learning in cardiology: Clinical application and basic research. Journal of Cardiology. 2023. 82. 2. 128-133
  • Hidenori Kojima, Taketaro Sadahiro, Naoto Muraoka, Hiroyuki Yamakawa, Hisayuki Hashimoto, Ryota Ishii, Masahiko Gosho, Yuto Abe, Yu Yamada, Koji Nakano, et al. MEF2C/p300-mediated epigenetic remodeling promotes the maturation of induced cardiomyocytes. Stem Cell Reports. 2023. 18. 6. 1274-1283
  • 小室 仁, 橋本 寿之, 勝木 俊臣, 楠本 大, 湯浅 慎介, 福田 恵一. Single cell解析に基づく心不全特異的な線維芽細胞集団を標的とした心不全の新規治療戦略. 心臓. 2022. 54. 12. 1405-1405
  • Jin Komuro, Yuta Tokuoka, Tomohisa Seki, Dai Kusumoto, Hisayuki Hashimoto, Toshiomi Katsuki, Takahiro Nakamura, Yohei Akiba, Thukaa Kuoka, Mai Kimura, et al. Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning. Biochemical and Biophysical Research Communications. 2022. 632. 181-188
  • Shogo Ito, Hisayuki Hashimoto, Hiroyuki Yamakawa, Dai Kusumoto, Yohei Akiba, Takahiro Nakamura, Mizuki Momoi, Jin Komuro, Toshiomi Katsuki, Mai Kimura, et al. The complement C3-complement factor D-C3a receptor signalling axis regulates cardiac remodelling in right ventricular failure. Nature communications. 2022. 13. 1. 5409-5409
more...
MISC (6):
Lectures and oral presentations  (17):
  • Cardiac Reprogramming Inducer ZNF281 is Indispensable for Heart Development by Interacting with Key Cardiac Transcriptional Factors
    (Basic Cardiovascular Sciences Scientific Session 2022 2022)
  • Cell fate conversion by epigenome editing
    (The 5th JCS Council Forum on Basic CardioVascular Research 2021)
  • Dissecting the Molecular Mechanism of Cardiac Reprogramming by Epigenetic Analysis
    (2020)
  • Synergistic activation of the cardiac enhancer landscape during reprogramming
    (European Society of Cardiology 2019)
  • エピジェネティクス解析を用いた心筋リプログラミングの分子機構の解明
    (第40回日本循環制御医学会 総会・学術集会 2019)
more...
Education (3):
  • 2008 - 2012 Keio University Graduate School of Medicine
  • 2000 - 2006 Keio University School of Medicine
  • 1998 - 2000 慶應義塾高等学校
Work history (10):
  • 2022/04 - 現在 Keio University School of Medicine Department of Cardiology
  • 2019/10 - 2022/03 Keio University School of Medicine Center for Preventive Medicine
  • 2018/11 - 2019/09 Keio University School of Medicine Department of Emergency and Critical Care Medicine
  • 2015/10 - 2018/10 University of Texas Southwestern Medical Center Department of Molecular Biology Postdoctoral Fellow
  • 2014/04 - 2015/09 平塚市民病院 循環器内科 医長
Show all
Awards (10):
  • 2022/07 - American Heart Association Basic Cardiovascular Sciences Scientific Session 2022 Paul Dudley White International Scholar
  • 2022/07 - American Heart Association Basic Cardiovascular Sciences Scientific Session 2022 Outstanding Early Career Investigator Award
  • 2021/03 - 東京都医師会 医学研究賞
  • 2020/08 - 日本循環器学会 循環器再生医科学賞
  • 2020/04 - Keio University Keio University School of Medicine Alumni Association (Sanshikai) Young Investigator Award
Show all
Association Membership(s) (6):
日本再生医療学会 ,  JAPANESE ASSOCIATION FOR ACUTE MEDICINE ,  国際心臓研究会 ,  The Japanese Circulation Society ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  日本ゲノム編集学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page